© 2007 The Royal College of Psychiatrists
Heroin-assisted treatment for opioid dependence
Randomised controlled trial
Centre for Interdisciplinary Addiction Research, University Medical Centre Eppendorf, Hamburg
Institute for Medical Biometrics and Epidemiology, University Medical Centre Eppendorf, Hamburg
Centre for Interdisciplinary Addiction Research, University Medical Centre, Eppendorf, Hamburg, Germany
Correspondence: Dr Christian Haasen, Centre for Interdisciplinary Addiction Research, Department of Psychiatry, University Medical Centre Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. Email: haasen{at}uke.uni-hamburg.de
Funding detailed in Acknowledgements.
Background Heroin-assisted treatment has been found to be effective for people with severe opioid dependence who are not interested in or do poorly on methadone maintenance.
Aims To study heroin-assisted treatment in people on methadone who continue intravenous heroin and in those who are heroin dependent but currently not in treatment.
Method In an open-label multicentre randomised controlled trial, 1015 people with heroin dependence received a variable dose of injectable heroin (n=515) or oral methadone (n=500) for 12 months. Two response criteria, improvement of physical and/or mental health and decrease in illicit drug use, were evaluated in an intent-to-treat analysis.
Results Retention was higher in the heroin (67.2%) than in the methadone group (40.0%) and the heroin group showed a significantly greater response on both primary outcome measures. More serious adverse events were found in the heroin group, and were mainly associated with intravenous use.
Conclusions Heroin-assisted treatment is more effective for people with opioid dependence who continue intravenous heroin while on methadone maintenance or who are not enrolled in treatment. Despite a higher risk, it should be considered for treatment resistance under medical supervision.
Related articles in BJP:
- From the Editor's desk
- Peter Tyrer
BJP 2007 191: 96.[Full Text] - Highlights of this issue
- Sukhwinder S. Shergill
BJP 2007 191: A2.[Full Text]
This article has been cited by other articles:
 |
|
 |
|
  W. v. d. Brink Heroin assisted treatment BMJ, November 6, 2009; 339(nov06_1): b4545 - b4545. [Full Text]
|
|
|
|
 |
|
 E. Oviedo-Joekes, S. Brissette, D. C. Marsh, P. Lauzon, D. Guh, A. Anis, and M. T. Schechter Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction N. Engl. J. Med., August 20, 2009; 361(8): 777 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Oviedo-Joekes, B. Nosyk, D. C Marsh, D. Guh, S. Brissette, C. Gartry, M. Krausz, A. Anis, and M. T Schechter Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: Rationale and design of the NAOMI study Clinical Trials, June 1, 2009; 6(3): 261 - 271. [Abstract] [PDF]
|
|
|
|
|
|
J. Rehm and B. Fischer Should heroin be prescribed to heroin misusers? Yes BMJ, January 12, 2008; 336(7635): 70 - 70. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Al-Adwani and R. Nahata Heroin-assisted treatment: no difference in treatment retention The British Journal of Psychiatry, November 1, 2007; 191(5): 458 - 458. [Full Text] [PDF]
|
|
eLetters:
Read all eLetters
- Important findings for heroin treatment but treatment retention not one of them
- Andrew Al-Adwani, et al.
- BJP Online, 5 Jul 2007 [Full text]
- Response to letter „Important findings for heroin treatment but treatment retention not one of them"
- Christian Haasen
- BJP Online, 7 Sep 2007 [Full text]